Genomic and transcriptomic analyses of SCLC and LCNEC also indicate an important overlap with common (biallelic) inactivation of TP53 and RB1, as recently reported by Lantuejoul and colleagues [23]. The gene discussed is TP53; the disease is large cell neuroendocrine carcinoma.